Urinalysis Market Size Worth USD 6.8 billion by 2033 at a CAGR of 8.3%

Urinalysis Market

Allied Market Research published a report, titled, “Urinalysis Market by Product (Instruments and Consumables), Application (Disease Screening and Pregnancy & Fertility Testing), End User (Hospitals, Clinical Laboratories and Home Care): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the urinalysis market was valued at $3.1 billion in 2023, and is estimated to reach $6.8 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.

๐–๐ก๐š๐ญ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐”๐ซ๐ข๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ?

The key factors driving the growth of urinalysis market are rise in prevalence of chronic kidney disease, technological advancement, and surge in geriatric population. According to World Health Organization, the geriatric population is expected to rise from 12% in 2015 to 22% in 2050. As individuals age, the prevalence of chronic and age-related diseases such as diabetes, hypertension, and urinary tract infections increases substantially. These conditions often necessitate regular urinalysis for effective monitoring and management. The elderly population is also more prone to kidney disorders, which further amplifies the demand for urinalysis as a non-invasive, cost-effective diagnostic tool.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž: https://www.alliedmarketresearch.com/request-sample/1055

๐“๐จ๐ฉ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐”๐ซ๐ข๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

  • Abbott Ltd
  • Sysmex Corporation
  • Siemens Healthcare GmbH
  • Acon Laboratories, Inc.
  • Arkray Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific Inc

๐”๐ซ๐ข๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐œ๐š๐ง ๐›๐ž ๐๐จ๐ง๐ž ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐ :

By product, consumable segment dominated the market share in 2023. Consumables include items such as reagents, dipsticks, and disposables, which are essential for routine urinalysis tests conducted in hospitals, clinics, and laboratories. The frequent need for these items, driven by the rising prevalence of chronic diseases like diabetes and kidney disorders, ensures a steady and continuous demand. Additionally, advancements in technology have led to the development of more sophisticated and accurate consumables, further boosting their usage.

By application, disease screening segment dominated the market share in 2023. This is attributed to high prevalence of urinary tract infection. Moreover, urinary tract infection can lead to severe complications if left untreated, underscoring the critical need for early detection and prompt intervention, further bolstering the demand for urinary tract infection screening tests. In addition, advancements in technology have significantly enhanced the performance and efficiency of urinary tract infection screening assays.

By end user, clinical laboratories segment dominated the market share in 2023. This is attributed to the fact that clinical laboratories serve as essential hubs for diagnostic testing, where a wide array of tests, including urinalysis, are conducted to aid in disease diagnosis, monitoring, and treatment. Moreover, clinical laboratories often have advanced equipment and trained personnel dedicated to performing urinalysis with high precision and efficiency, thereby have capacity to perform large number of tests. Additionally, the increasing prevalence of chronic diseases such as diabetes and kidney disorders necessitate frequent urinalysis testing for disease management and early detection of complications, further driving the demand for testing services offered by clinical laboratories.

In North America, particularly the U.S., the market growth is driven developed healthcare systems, advanced diagnostic technologies, and a high prevalence of urinary tract infections and chronic kidney diseases. The North America region is also witnessing a growing demand for point-of-care testing solutions, driving innovation and new product development. Europe also shows substantial market growth, driven by a well-established healthcare system and increasing prevalence of diabetes and ageing population. Countries like Germany, France, and the UK are key markets within Europe, benefiting from high levels of healthcare access and aging population.

In the Asia-Pacific region, the urinalysis market is experiencing rapid expansion. This growth is fueled by rapid urbanization, expanding healthcare access, and rising awareness about the importance of early disease detection. In addition, government initiatives to improve healthcare infrastructure and affordability are further propelling market expansion in countries like China and India.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/1055

๐Ž๐ฎ๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐ž๐ฌ ๐˜๐จ๐ฎ ๐€๐ง๐ฌ๐ฐ๐ž๐ซ ๐ญ๐จ ๐๐ž๐ฅ๐จ๐ฐ ๐Œ๐ž๐ง๐ญ๐ข๐จ๐ง๐ž๐ ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง:

  • Which are the driving factors responsible for the growth of market?
  • Which are the roadblock factors of this market?
  • What are the new opportunities, by which market will grow in coming years?
  • What are the trends of this market?
  • Which are main factors responsible for new product launch?
  • How big is the global & regional market in terms of revenue, sales and production?
  • How far will the market grow in forecast period in terms of revenue, sales and production?
  • Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
  • How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
  • Which region has more opportunities?

๐‘๐ž๐ ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:-

  • North America

(U.S., Canada, Mexico)

  • Europe

(Germany, France, UK, Italy, Spain, Rest of Europe)

  • Asia-Pacific

(Japan, China, India, Rest of Asia-Pacific)

  • LAMEA

(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ:

David Correa

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

[email protected]

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Allied Market Research

Allied Market Research

Allied Market Research (AMR) is approved by the Newstrail editorial board to share timely, data-driven insights. As a trusted leader in market research and analysis across multiple industries, AMR delivers in-depth reports and expert commentary to help businesses stay ahead of emerging trends.